NeuroSense Therapeutics L... (NRSNW)
NASDAQ: NRSNW
· Real-Time Price · USD
0.57
-0.12 (-17.39%)
At close: Aug 18, 2025, 1:30 PM
NeuroSense Therapeutics Revenue
NeuroSense Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2024, NeuroSense Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
17
Market Cap
14.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | n/a |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |